Mixed Financial Outcomes

ROVI's Q1 2026 results show a decrease in operating revenues by 1.5 % compared to Q1 2025, totaling EUR152.5 million. However, gross profit increased by 5 % to EUR95 million, with a significant improvement in gross margin of 3.8 percentage points to 62.3 %. The contract manufacturing business (CDMO) revenue grew by 5 %, while Okedi sales surged by 37 % year‑on‑year, contributing to the company's growth momentum. Despite these positive developments, R&D expenses rose by 79 % to EUR11.2 million, impacting overall profitability.